Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
Retatrutide 10MG
$110.00
Availability: 15 in stock
Retatrutide is a synthetic triple receptor agonist designed to simultaneously activate the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This investigational peptide has attracted significant attention in metabolic research for its potential to influence energy expenditure, appetite regulation, glucose metabolism, and body weight. Ongoing preclinical and clinical studies continue to evaluate its pharmacological profile and its role in advancing research on obesity, metabolic disorders, and cardiometabolic health.
For research use only. Not for human consumption.
References:
Jastreboff AM et al., New England Journal of Medicine, 2023 389(6):514-526.
Coskun T et al., Molecular Metabolism, 2022 62:101530.
Müller TD et al., Nature Reviews Drug Discovery, 2022 21(3):201-223.